GlySens Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Series F

  • Latest Deal Amount
  • $15M

  • Investors
  • 7

GlySens General Information

Description

Developer of glucose monitoring devices designed to improve the lives of people with diabetes. The company's implantable device empowers individuals with easy, at-a-glance, worry-free diabetes technology to check and improve their glucose levels, enabling patients to access information through continuous monitoring to optimize care and live life on their terms.

Contact Information

Website
www.glysens.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3931 Sorrento Valley Boulevard
  • Suite 110
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Digital Health, Wearables & Quantified Self, HealthTech
Corporate Office
  • 3931 Sorrento Valley Boulevard
  • Suite 110
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GlySens Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC (Series F) 12-Jun-2020 $15M Completed Clinical Trials - Phase 4
10. Debt - PPP 15-Apr-2020 Completed Clinical Trials - Phase 4
9. Later Stage VC (Series E) 13-Nov-2018 Completed Pre-Clinical Trials
8. Later Stage VC (Series D) 05-Jan-2016 Completed Pre-Clinical Trials
7. Grant 19-Sep-2015 Completed Pre-Clinical Trials
6. Later Stage VC (Series C) 05-Jan-2015 Completed Pre-Clinical Trials
5. Grant 24-Nov-2014 Completed Pre-Clinical Trials
4. Later Stage VC (Series B) 12-Sep-2012 Completed Pre-Clinical Trials
3. Later Stage VC (Series B) 27-Nov-2007 $6M $6.35M Completed Pre-Clinical Trials
2. Angel (individual) 26-Aug-2004 $350K $350K Completed Product Development
To view GlySens’s complete valuation and funding history, request access »

GlySens Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series F
Series E
Series D
Series C
Series B-1
Series B 4,138,884 $0.000100 8% $2.25 $2.25 1x $2.25 11.64%
Series A 540,000 $0.000100 8% $0.83 $0.83 1x $0.83 1.52%
To view GlySens’s complete cap table history, request access »

GlySens Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of glucose monitoring devices designed to improve the lives of people with diabetes. The company's implantable
Monitoring Equipment
San Diego, CA
30 As of 2022

Basel, Switzerland
 

Malvern, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

GlySens Competitors (14)

One of GlySens’s 14 competitors is Ascensia Diabetes Care, a Formerly PE-Backed company based in Basel, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ascensia Diabetes Care Formerly PE-Backed Basel, Switzerland
LifeScan Formerly PE-Backed Malvern, PA
Cnoga Formerly VC-backed Caesarea, Israel
Jana Care Venture Capital-Backed Watertown, MA
GlucoTrack Technologies Corporate Backed or Acquired Rutherford, NJ
You’re viewing 5 of 14 competitors. Get the full list »

GlySens Patents

  • 35

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • Pending

  • Expiring in next 12 mo

GlySens Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2020006307-A1 Apparatus and methods for analyte sensor spatial mismatch mitigation and correction Inactive 27-Jun-2018
EP-3809968-A1 Analyte sensor apparatus and methods Inactive 19-Jun-2018
EP-3809968-A4 Analyte sensor apparatus and methods Inactive 19-Jun-2018
WO-2019246133-A1 Analyte sensor apparatus and methods Inactive 19-Jun-2018
WO-2019135988-A1 Apparatus and methods for analyte sensor mismatch correction Inactive 04-Jan-2018 G01N33/4925
To view GlySens’s complete patent history, request access »

GlySens Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GlySens Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
McNair Interests Real Estate Minority
The Sarofim Group Venture Capital Minority
U.S. Department of Health and Human Services Government
Fayez Sarofim Hedge Fund Minority
West Health Investment Fund Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

GlySens FAQs

  • When was GlySens founded?

    GlySens was founded in 1997.

  • Where is GlySens headquartered?

    GlySens is headquartered in San Diego, CA.

  • What is the size of GlySens?

    GlySens has 30 total employees.

  • What industry is GlySens in?

    GlySens’s primary industry is Monitoring Equipment.

  • Is GlySens a private or public company?

    GlySens is a Private company.

  • What is the current valuation of GlySens?

    The current valuation of GlySens is .

  • What is GlySens’s current revenue?

    The current revenue for GlySens is .

  • How much funding has GlySens raised over time?

    GlySens has raised $65.4M.

  • Who are GlySens’s investors?

    McNair Interests, The Sarofim Group, U.S. Department of Health and Human Services, Fayez Sarofim, and West Health Investment Fund are 5 of 7 investors who have invested in GlySens.

  • Who are GlySens’s competitors?

    Ascensia Diabetes Care, LifeScan, Cnoga, Jana Care, and GlucoTrack Technologies are some of the 14 competitors of GlySens.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process